Canopy Growth Corporation
TSX:WEED.TODrug Manufacturers - Specialty & Generic
+$0.03 today
- Market cap
- $323.72M
- Beta
- 2.41
- P/E (TTM)
- -1.8
- EPS (TTM)
- -$0.76
Volume 1.16M
Average 2.07M
WEED.TO EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Canopy Growth CorporationTSX: WEED.TO
EBITDA · Q4 FY2025 · quarter ended Mar 2026
EBITDA remains negative
Q4 FY2025 EBITDA was -CA$18.82M, compared with -CA$194.32M a year earlier. Trailing-twelve-month EBITDA was -CA$63.48M.
Context
- EBITDA amounted to 66.1% of revenue in FY2025, down 112.1 pp from a year earlier.
- EBITDA grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 7 analysts of CA$50.62M (+126.9%) for the fiscal year ending Mar 2027, a step up from the +60.7% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -CA$18.82M+59.1% QoQ
- Last fiscal yearMar 2026
- -CA$188.22M+60.7% YoY
- LTMMar 2026
- -CA$63.48M+86.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +90.3% | +123.6% | +33.3 pp |
| 1 year | +60.7% | +126.9% | +66.2 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
CAD · from the income statement
- Latest · FY2025
- (188.22M) CAD
- Year-over-year change
- +60.7%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2026-03-31 | (188.22M) | +60.7% |
| FY2024 | 2025-03-31 | (479.31M) | -53.2% |
| FY2023 | 2024-03-31 | (312.83M) | +89.1% |
| FY2022 | 2023-03-31 | (2.88B) | -5336.5% |
| FY2021 | 2022-03-31 | (52.98M) | — |
EBITDA vs competitors
How WEED.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +86.8% is the 3rd highest of 8, against a peer median of +45.8%.
- EBITDA amounts to 20.4% of revenue for WEED.TO, versus a peer median of 23.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $60.46M USD | +510.4% | — | 23.1% | |
| LTM Mar 2026 | CA$49.15M CAD | +45.8% | — | 31.0% | |
| LTM Mar 2026 | $25.12M USD | +96.0% | +26.0% | 49.3% | |
| LTM Mar 2026 | CA$9.82M CAD | -80.9% | — | 3.1% | |
| LTM Mar 2026 | -$5.36M USD | +48.2% | — | 10.5% | |
| LTM Mar 2026 | -CA$35.21M CAD | -81.6% | — | 1275.3% | |
| LTM Mar 2026 | -CA$40.84M CAD | -681.4% | — | 14.9% | |
| LTM Mar 2026 | -CA$63.48M CAD | +86.8% | — | 20.4% | |
| Peer median (excluding WEED.TO) | — | +45.8% | +26.0% | 23.1% | |
Competitors are the stored peer set for WEED.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Mar 2022 | FY2022 Mar 2023 | FY2023 Mar 2024 | FY2024 Mar 2025 | FY2025 Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 475.7M | 333.25M | 297.15M | 269M | 284.6M |
| Cost of Revenue | 653.93M | 431.64M | 216.26M | 189.48M | 214.93M |
| Gross Profit | (143.6M) | (98.38M) | 80.88M | 79.51M | 69.67M |
| Gross Margin | -30.2% | -29.5% | 27.2% | 29.6% | 24.5% |
| Research & Development | 32.26M | 21.72M | 4.61M | 2.74M | 0 |
| Selling, General & Admin | 361.1M | 297.98M | 175.98M | 121.71M | 122.93M |
| Operating Expenses | 445.08M | 297.4M | 309.6M | 196.65M | 142.78M |
| Depreciation & Amortization | 110.94M | 80.03M | 53.18M | 43.12M | 36.47M |
| EBITDA | (52.98M) | (2.88B) | (312.83M) | (479.31M) | (188.22M) |
| EBITDA Margin | -11.1% | -864.2% | -105.3% | -178.2% | -66.1% |
| Operating Income | (588.69M) | (395.78M) | (228.71M) | (117.14M) | (73.11M) |
| Operating Margin | -123.8% | -118.8% | -77.0% | -43.5% | -25.7% |
| Interest Income | 6.6M | 24.28M | 16.24M | 8.82M | 10M |
| Interest Expense | 103.94M | 126.16M | 105.35M | 74.57M | 38.19M |
| Other Income / Expenses | 370.63M | (2.69B) | (242.64M) | (479.85M) | (189.78M) |
| Income Before Tax | (267.86M) | (3.09B) | (471.36M) | (597M) | (262.89M) |
| Pre-Tax Margin | -56.3% | -926.1% | -158.6% | -221.9% | -92.4% |
| Income Tax Expense | (8.95M) | (5.73M) | 12.33M | 7.14M | 23K |
| Net Income | (310.04M) | (3.28B) | (657.27M) | (598.12M) | (262.91M) |
| Net Margin | -65.2% | -983.7% | -221.2% | -222.4% | -92.4% |
| EPS (Basic) | (0.81) | (12.18) | (8.79) | (5.56) | (0.76) |
| EPS (Diluted) | (0.81) | (12.18) | (8.79) | (5.56) | (0.76) |
| Weighted Avg Shares | 396.1M | 271.61M | 74.79M | 107.55M | 345.53M |
| Weighted Avg Shares (Diluted) | 396.36M | 271.61M | 74.79M | 107.55M | 345.53M |
Canopy Growth Corporation
TSX:WEED.TO
Intrinsic Alpha fair value
Locked
Current Price
$0.72
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.